Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Arctic Bioscience AS FCF Yield % Related Terms
Arctic Bioscience AS FCF Yield % Historical Data
* Premium members only.
The historical data trend for Arctic Bioscience AS's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:9TD vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Arctic Bioscience AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arctic Bioscience AS FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Arctic Bioscience AS's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arctic Bioscience AS (FRA:9TD) has a FCF Yield % of -56.14 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Arctic Bioscience AS and its competitors. According to the industry distribution chart, Arctic Bioscience AS ranks #1191 out of 1409 companies in the Biotechnology industry, placing it in the top 84.5%.
Is Arctic Bioscience AS's FCF Yield % too high?
Arctic Bioscience AS's current FCF Yield % is -56.14. Based on the distribution chart, Arctic Bioscience AS ranks #1191 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arctic Bioscience AS has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arctic Bioscience AS ranks #1191 out of 1409 companies for FCF Yield %. This places Arctic Bioscience AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current FCF Yield % is -56.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (FRA:9TD) is currently considered Possible Value Trap. The stock's GF Value™ is €1.02, compared to a current price of €0.24 — trading 76.2% below its estimated fair value. The current FCF Yield % is -56.14. Arctic Bioscience AS's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Arctic Bioscience AS (FRA:9TD), the current FCF Yield % is -56.14 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arctic Bioscience AS (FRA:9TD) Overvalued in 2026?
Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued.
The current stock price of €0.24 is trading 76.2% below its estimated GF Value™ of €1.02.
GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.
Key valuation signals for FRA:9TD:
FCF Yield %: -56.14
GF Value™: €1.02 vs. price of €0.24 (76.2% below fair value)
No single metric tells the full story. See the FRA:9TD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
57GF Score
Get the complete analysis for FRA:9TD
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9TD has been successfully added to your 
